Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W C Nichols

Showing results (21-30 of 78) with videos related to

Pageof 8
Sort By:
American Journal of Medical Genetics|June 15, 1991
Biochemical and clinical characterization of prealbuminCHICAGO: an apparently benign variant of serum prealbumin (transthyretin) discovered with high-resolution two-dimensional electrophoresisH H Harrison, E D Gordon, W C Nichols, et al.
Journal of Medical Genetics|November 1, 1987
Familial t(8;15)(p23.3;q22.3): report of two cases with dup(15) (q22.3----qter)D J Goldstein, R E Ward, W C Nichols, et al.
Cancer Treatment Reports|March 1, 1981
Phase II trial of indicine N-oxide (INDI) in patients with advanced colorectal carcinomaW C Nichols, C G Moertel, J Rubin, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1991
Severe von Willebrand disease due to a defect at the level of von Willebrand factor mRNA expression: detection by exonic PCR-restriction fragment length polymorphism analysisW C Nichols, S E Lyons, J S Harrison, et al.
Cancer|April 15, 1981
Malignant, predominantly lymphocytic thymoma with central and peripheral nervous system metastasesM R Wick, W C Nichols, J N Ingle, et al.
Cancer Treatment Reports|March 1, 1986
Phase II trial of diaziquone in malignant mesotheliomaR T Eagan, S Frytak, R L Richardson, et al.
Cancer Treatment Reports|July 1, 1984
Phase I study of diaziquoneS Frytak, R T Eagan, M M Ames, et al.
American Journal of Clinical Oncology|February 1, 1986
Phase II study of the three-drug combination of mitomycin C, CCNU, and methotrexate (MCM) in advanced non-small cell lung cancerR T Eagan, S Frytak, R L Richardson, et al.
Cancer Treatment Reports|August 1, 1982
Phase II study on DON in patients with previously treated advanced lung cancerR T Eagan, S Frytak, W C Nichols, et al.
Annals of Neurology|May 1, 1990
Diagnosis of Maryland/German familial amyloidotic polyneuropathy using allele-specific, enzymatically amplified, genomic DNAJ R Mendell, X S Jiang, J R Warmolts, et al.
Pageof 8

Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
American Journal of Medical Genetics|June 15, 1991
Biochemical and clinical characterization of prealbuminCHICAGO: an apparently benign variant of serum prealbumin (transthyretin) discovered with high-resolution two-dimensional electrophoresisH H Harrison, E D Gordon, W C Nichols, et al.
Journal of Medical Genetics|November 1, 1987
Familial t(8;15)(p23.3;q22.3): report of two cases with dup(15) (q22.3----qter)D J Goldstein, R E Ward, W C Nichols, et al.
Cancer Treatment Reports|March 1, 1981
Phase II trial of indicine N-oxide (INDI) in patients with advanced colorectal carcinomaW C Nichols, C G Moertel, J Rubin, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1991
Severe von Willebrand disease due to a defect at the level of von Willebrand factor mRNA expression: detection by exonic PCR-restriction fragment length polymorphism analysisW C Nichols, S E Lyons, J S Harrison, et al.
Cancer|April 15, 1981
Malignant, predominantly lymphocytic thymoma with central and peripheral nervous system metastasesM R Wick, W C Nichols, J N Ingle, et al.
Cancer Treatment Reports|March 1, 1986
Phase II trial of diaziquone in malignant mesotheliomaR T Eagan, S Frytak, R L Richardson, et al.
Cancer Treatment Reports|July 1, 1984
Phase I study of diaziquoneS Frytak, R T Eagan, M M Ames, et al.
American Journal of Clinical Oncology|February 1, 1986
Phase II study of the three-drug combination of mitomycin C, CCNU, and methotrexate (MCM) in advanced non-small cell lung cancerR T Eagan, S Frytak, R L Richardson, et al.
Cancer Treatment Reports|August 1, 1982
Phase II study on DON in patients with previously treated advanced lung cancerR T Eagan, S Frytak, W C Nichols, et al.
Annals of Neurology|May 1, 1990
Diagnosis of Maryland/German familial amyloidotic polyneuropathy using allele-specific, enzymatically amplified, genomic DNAJ R Mendell, X S Jiang, J R Warmolts, et al.
Pageof 8